{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:29:21Z","timestamp":1791296961241,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.healun.2014.09.038","type":"journal-article","created":{"date-parts":[[2014,10,3]],"date-time":"2014-10-03T21:18:18Z","timestamp":1412371098000},"page":"604-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Natural killer cell deficiency in patients with non-Hodgkin lymphoma after lung transplantation"],"prefix":"10.1016","volume":"34","author":[{"given":"Florence","family":"Baychelier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abla","family":"Achour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Raphael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Toubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Besson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle","family":"Arnoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Roos-Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Marty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Chapelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Debr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9362-3922","authenticated-orcid":false,"given":"Vincent","family":"Vieillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2014.09.038_bib1","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2014.09.038_bib2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2014.09.038_bib3","doi-asserted-by":"crossref","first-page":"430209","DOI":"10.1155\/2013\/430209","article-title":"Posttransplant lymphoproliferative disease after lung transplantation","volume":"2013","author":"Neuringer","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.healun.2014.09.038_bib4","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1600-6143.2009.02898.x","article-title":"AST Infectious Diseases Community of Practice. Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients","volume":"9","author":"Allen","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2014.09.038_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N Eng J Med"},{"key":"10.1016\/j.healun.2014.09.038_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1034\/j.1399-3062.2001.003003177.x","article-title":"Epstein-Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate","volume":"3","author":"Mentzer","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2014.09.038_bib7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/MOT.0b013e3283651b0d","article-title":"Cancer-infection interface in children after transplantation: posttransplant lymphoproliferative disorder and Epstein-Barr virus infection","volume":"18","author":"Fujieda","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.healun.2014.09.038_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.trim.2006.10.006","article-title":"Quantitative analysis of EBV-specific CD4\/CD8 T cell numbers, absolute CD4\/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD","volume":"17","author":"Sebelin-Wulf","year":"2007","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.healun.2014.09.038_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3324\/haematol.10595","article-title":"CHOP-21 for the treatment of post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation","volume":"92","author":"Choquet","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.healun.2014.09.038_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1470-2045(11)70300-X","article-title":"Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial","volume":"13","author":"Trappe","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.healun.2014.09.038_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nri3174","article-title":"Targeting natural killer cells and natural killer T cells in cancer","volume":"12","author":"Vivier","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.healun.2014.09.038_bib12","doi-asserted-by":"crossref","first-page":"e11966","DOI":"10.1371\/journal.pone.0011966","article-title":"NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs","volume":"5","author":"B\u00e9ziat","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2014.09.038_bib13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.it.2013.01.003","article-title":"Activating natural cytotoxicity receptors of natural killer cells in cancer and infection","volume":"34","author":"Koch","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.healun.2014.09.038_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"Raulet","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.healun.2014.09.038_bib15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2141.2005.05452.x","article-title":"The immune response to primary EBV infection: a role for natural killer cells","volume":"129","author":"Williams","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.healun.2014.09.038_bib16","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1371\/journal.ppat.0040027","article-title":"Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma","volume":"4","author":"Strowig","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.healun.2014.09.038_bib17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.19.1.657","article-title":"X-linked lymphoproliferative disease: a progressive immunodeficiency","volume":"19","author":"Morra","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.healun.2014.09.038_bib18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1172\/JCI12932","article-title":"GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder","volume":"108","author":"Baiocchi","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2014.09.038_bib19","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1158\/0008-5472.CAN-03-2862","article-title":"Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship","volume":"64","author":"Dall\u2019Ozzo","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.healun.2014.09.038_bib20","doi-asserted-by":"crossref","first-page":"13446","DOI":"10.1128\/JVI.02382-13","article-title":"Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells","volume":"87","author":"Saghafian-Hedengren","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.healun.2014.09.038_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1084\/jem.20100762","article-title":"Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus","volume":"208","author":"Bj\u00f6rkstr\u00f6m","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.healun.2014.09.038_bib22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/eji.201141826","article-title":"CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients","volume":"42","author":"B\u00e9ziat","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.healun.2014.09.038_bib23","doi-asserted-by":"crossref","first-page":"e1002268","DOI":"10.1371\/journal.ppat.1002268","article-title":"Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity","volume":"7","author":"Petitdemange","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.healun.2014.09.038_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4049\/jimmunol.1301951","article-title":"Expansion of CMV-mediated NKG2C+ NK cells associates with the development of specific de novo malignancies in liver-transplanted patients","volume":"192","author":"Achour","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2014.09.038_bib25","doi-asserted-by":"crossref","first-page":"e28782","DOI":"10.4161\/onci.28782","article-title":"Transplantation induced cancers: emerging evidence that clonal CMV-specific NK cells are causal immunogenic factor","volume":"3","author":"Achour","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.healun.2014.09.038_bib26","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.healun.2014.09.038_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000339722","article-title":"Epstein-Barr virus infection and altered control of apoptotic pathways in posttransplant lymphoproliferative disorders","volume":"80","author":"Ghigna","year":"2013","journal-title":"Pathobiology"},{"key":"10.1016\/j.healun.2014.09.038_bib28","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.4049\/jimmunol.160.10.4951","article-title":"HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences","volume":"160","author":"Lee","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2014.09.038_bib29","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1038\/sj.onc.1205554","article-title":"Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells","volume":"21","author":"Fagard","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.healun.2014.09.038_bib30","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1182\/blood-2010-11-319194","article-title":"Human NKG2A overrides NKG2C effector functions to prevent autoreactivity of NK cells","volume":"117","author":"B\u00e9ziat","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.healun.2014.09.038_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbmt.2010.08.014","article-title":"Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen","volume":"17","author":"Ohata","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.healun.2014.09.038_bib32","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nri911","article-title":"Functional significance of the perforin\/granzyme cell death pathway","volume":"2","author":"Trapani","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.healun.2014.09.038_bib33","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1182\/blood-2005-07-2880","article-title":"Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2","volume":"107","author":"Godal","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.healun.2014.09.038_bib34","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1182\/blood-2004-10-4113","article-title":"NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect","volume":"105","author":"Nguyen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.healun.2014.09.038_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1182\/blood-2011-08-372003","article-title":"Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?","volume":"119","author":"Della Chiesa","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.healun.2014.09.038_bib36","first-page":"6178","article-title":"Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity","volume":"62","author":"Pende","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.healun.2014.09.038_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/eji.201141832","article-title":"Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD","volume":"42","author":"Wiesmayr","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.healun.2014.09.038_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.tp.0000296817.28053.7b","article-title":"Rapamycin, but not cyclosporine or FK506, alters natural killer cell function","volume":"85","author":"Wai","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2014.09.038_bib39","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1182\/blood-2006-10-048173","article-title":"The unexpected effect of cyclosporin A on CD56+CD16\u2212 and CD56+CD16+ natural killer cell subpopulations","volume":"110","author":"Wang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.healun.2014.09.038_bib40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1474-9726.2010.00584.x","article-title":"Human NK cells display major phenotypic and functional changes over the life span","volume":"9","author":"Le Garff-Tavernier","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/j.healun.2014.09.038_bib41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7150\/jca.2.443","article-title":"Tumor induced inactivation of natural killer cell cytotoxic function; implication in growth, expansion and differentiation of cancer stem cells","volume":"2","author":"Jewett","year":"2011","journal-title":"J Cancer"},{"key":"10.1016\/j.healun.2014.09.038_bib42","first-page":"5610","article-title":"Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma","volume":"53","author":"Nakagomi","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.healun.2014.09.038_bib43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.40.1.113","article-title":"T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma","volume":"40","author":"Mulder","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.healun.2014.09.038_bib44","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00262-007-0375-3","article-title":"Potential contribution of na\u00efve immune effectors to oral tumor resistance: role in synergistic induction of VEGF, IL-6, and IL-8 secretion","volume":"57","author":"Teruel","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.healun.2014.09.038_bib45","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1086\/650455","article-title":"High level of perforin expression in T cells: an early prognostic marker of the severity of herpesvirus reactivation after allogeneic stem cell transplantation in adults","volume":"50","author":"Pietersma","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2014.09.038_bib46","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/eji.201242733","article-title":"At diagnosis, diffuse large B-cell lymphoma patients show impaired rituximab-mediated NK-cell cytotoxicity","volume":"43","author":"Danielou-Lazareth","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.healun.2014.09.038_bib47","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.192.5.755","article-title":"Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma","volume":"192","author":"Smyth","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.healun.2014.09.038_bib48","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.healun.2014.09.038_bib49","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev-med-041610-134208","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","volume":"63","author":"Janka","year":"2012","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.healun.2014.09.038_bib50","doi-asserted-by":"crossref","first-page":"e24185","DOI":"10.4161\/onci.24185","article-title":"Human perforin mutations and susceptibility to multiple primary cancers","volume":"2","author":"Trapani","year":"2013","journal-title":"Oncoimmunology"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249814013734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249814013734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:28:41Z","timestamp":1760948921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249814013734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1053249814013734"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2014.09.038","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural killer cell deficiency in patients with non-Hodgkin lymphoma after lung transplantation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2014.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}